Clinical Study
A Randomized, Double-Blind, Placebo-Controlled, Multicentre Trial of the Effects of a Shrimp Protein Hydrolysate on Blood Pressure
Table 4
Changes in office blood pressure for all subjects in the ITT population during the 8-week supplementation period.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ANCOVA: analysis of covariance; DBP: diastolic blood pressure; ITT: intention-to-treat; mmHg: millimeter of mercury; RPC: Refined Peptide Concentrate; SBP: systolic blood pressure; SD: standard deviation; W: week -group comparisons of the changes from W 0 to W 2, W 0 to W 4, and W 0 to W 8 were made using the paired Student t-test. Between-group comparisons of the changes from W 0 to W 2, W 0 to W 4, and W 0 to W 8 were made using ANCOVA with the value at baseline used as the covariate. p≤0.05 was considered statistically significant. |